Home NEWS / PRESS RELEASES

NEWS / PRESS RELEASES

Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product...

Cure Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology announced today that it has entered into a product development agreement with Therapix Biosciences...